When spatial heterogeneity of ventricular repolarization (SHVR) increases, vulnerability to ventricular arrhythmias, including lethal ones, has also been observed to increase. Drug-induced multi-ion-channel blocks may increase SHVR. Aim of this study is to non-invasively assess whether quinidine, a strong hERG potassium channel blocker with weaker effects on calcium and late sodium currents, increases SHVR. We analyzed data from 21 healthy subjects that received both the drug and a placebo and underwent to 12 leads Holter monitoring. From the recording, three 10-s ECGs were extracted at each of 16 predefined time-points. SHVR was assessed by the ν- index, which evaluates the standard deviation of the repolarization times from multi-lead ECG recordings. At any time point, a value of ν-index was computed for each of the three 10s ECGs and averaged if the difference in the mean RR of the 10s ECGs was lower than 50 ms. The ν- index did not change after the placebo (ν-index pre-dose = 29.2 ± 9.9 ms vs. ν-index post-dose1h = 26.7 ± 10.3, ns), whereas, after quinidine, it significantly increased one hour post-dose (ν-index pre-dose = 29.5 ± 10.2 ms vs. ν- index post-dose1h = 46.5 ± 33.8 ms, p = 0.01). Quinidine had its maximum effect on the ν-index 2.5 h after dose (ν-index post-dose2.5h = 53.6 ± 39.6 ms).
Assessment of Spatial Heterogeneity of Ventricular Repolarization after Quinidine in Healthy Subjects / V. Corino, R. Sassi, L. Mainardi, M.W. Rivolta - In: 2017 Computing in Cardiology (CinC)[s.l] : IEEE press, 2018. - ISBN 9781538666302. - pp. 1-4 (( Intervento presentato al 44. convegno Computing in Cardiology tenutosi a Rennes nel 2017 [10.22489/CinC.2017.222-107].
Assessment of Spatial Heterogeneity of Ventricular Repolarization after Quinidine in Healthy Subjects
R. Sassi;M.W. Rivolta
2018
Abstract
When spatial heterogeneity of ventricular repolarization (SHVR) increases, vulnerability to ventricular arrhythmias, including lethal ones, has also been observed to increase. Drug-induced multi-ion-channel blocks may increase SHVR. Aim of this study is to non-invasively assess whether quinidine, a strong hERG potassium channel blocker with weaker effects on calcium and late sodium currents, increases SHVR. We analyzed data from 21 healthy subjects that received both the drug and a placebo and underwent to 12 leads Holter monitoring. From the recording, three 10-s ECGs were extracted at each of 16 predefined time-points. SHVR was assessed by the ν- index, which evaluates the standard deviation of the repolarization times from multi-lead ECG recordings. At any time point, a value of ν-index was computed for each of the three 10s ECGs and averaged if the difference in the mean RR of the 10s ECGs was lower than 50 ms. The ν- index did not change after the placebo (ν-index pre-dose = 29.2 ± 9.9 ms vs. ν-index post-dose1h = 26.7 ± 10.3, ns), whereas, after quinidine, it significantly increased one hour post-dose (ν-index pre-dose = 29.5 ± 10.2 ms vs. ν- index post-dose1h = 46.5 ± 33.8 ms, p = 0.01). Quinidine had its maximum effect on the ν-index 2.5 h after dose (ν-index post-dose2.5h = 53.6 ± 39.6 ms).File | Dimensione | Formato | |
---|---|---|---|
222-107.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
224.69 kB
Formato
Adobe PDF
|
224.69 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.